RSS
RESEARCH UPDATE
DBT Skills May Reduce Polypharmacy in Borderline Personality Disorder
Simon M. Dosovitz, MD. Dr. Dosovitz has no financial relationships with companies related to this material.
General Psychiatry
RESEARCH UPDATE
Should We Use Two Antidepressants to Treat Unipolar Depression?
Paul Riordan, MD. Dr. Riordan has no financial relationships with companies related to this material.
EXPERT Q&A
20 Years of The Carlat Report
Daniel Carlat, MD.
Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
CLINICAL UPDATE
Viibryd Goes Generic, But Is It Worth Prescribing?
Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has no financial relationships with companies related to this material.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
